Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 20 recruiting now early-phase tilt

Cigarette Smoking: early-phase trial registry

20 of 46 indexed Cigarette Smoking trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #312 of 28,707 conditions by registered trial count.

46 US clinical trials · 20 currently recruiting · #312 of 28,707 conditions by registered trial count

Cigarette Smoking: 46 US clinical trials tracked, 20 recruiting.

Cigarette Smoking is the subject of 46 registered US clinical trials on ClinicalTrials.gov, 20 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is Medical University of South Carolina, running 4 of these trials.

Enrollment posture brief

Registry condition cigarette-smoking

OPEN 20 | RECR 43% | LATE 2 | EARLY 15 | RANK #312 | SPON 4

Nearest open-share peer: Diet Habit (43% recruiting · 23 trials)

Cognitive Dysfunction50%Hematologic Malignancies47.8%Endothelial Dysfunction45.7%Cigarette Smoking (this)43%Clear Cell Renal Cell Carcin30.4%
Open-enrollment share among volume-matched conditions near Cigarette Smoking

Cigarette Smoking lists 20 open slots (43% of 46 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cigarette Smoking on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cigarette Smoking is recruiting above its size-band peers.

    20 of 46 indexed trials (43.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Cigarette Smoking trials is spread across many organizations.

    Medical University of South Carolina accounts for 4 of 46 trials (8.7%). 30 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cigarette Smoking enrolment sits around 87 participants.

    Median target enrolment is 87 among the 46 trials that report a genuine target (sentinel values excluded). 24 of those (52.2%) plan for fewer than 100 participants.

  4. Cigarette Smoking research is mostly interventional.

    45 interventional and 1 observational studies make up this index (97.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 17Phase 28Phase 42

Open and recent trials

46 total, page 1 of 1

RECRUITING NA 544 participants

A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse

Medical University of South Carolina

NCT06118502

RECRUITING NA 482 participants

The Positively Quit Trial for Smoking Cessation

University of South Florida

NCT04449458

RECRUITING NA 472 participants

Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit

Abramson Cancer Center at Penn Medicine

NCT07199517

RECRUITING NA 316 participants

Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing

Virginia Polytechnic Institute and State University

NCT07142668

RECRUITING Phase 2 302 participants

E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

NYU Langone Health

NCT05722561

RECRUITING NA 225 participants

Switch or Quit R01

Medical University of South Carolina

NCT06373679

RECRUITING NA 210 participants

The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers

Abramson Cancer Center at Penn Medicine

NCT06264154

RECRUITING NA 200 participants

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

Abramson Cancer Center at Penn Medicine

NCT06372899

RECRUITING Phase 2 197 participants

Semaglutide for Post-Smoking Cessation Weight Management

The University of Texas Health Science Center, Houston

NCT06173778

RECRUITING Phase 1 100 participants

Effect of Cannabis on Cigarette Use Behavior

Johns Hopkins University

NCT06609083

RECRUITING Phase 4 80 participants

Beta-Adrenergic Modulation of Drug Cue Reactivity

University of Oklahoma

NCT05587361

RECRUITING NA 70 participants

Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing

Virginia Polytechnic Institute and State University

NCT07161050

RECRUITING NA 68 participants

Menthol, Inflammation, and Nicotine Transition Study

Rosalind Franklin University of Medicine and Science

NCT06232447

RECRUITING NA 64 participants

RTMS Targets Neural Circuits for Smoking Cessation

Medical University of South Carolina

NCT04903028

RECRUITING NA 60 participants

E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness

NYU Langone Health

NCT05815199

RECRUITING NA 50 participants

Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches

Medical University of South Carolina

NCT06678789

RECRUITING NA 48 participants

Smoking Cessation Intervention for American Indian Women Experiencing Intimate Partner Violence

Black Hills Center for American Indian Health

NCT06357767

RECRUITING NA 46 participants

Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults

University of Chicago

NCT06395415

RECRUITING Phase 1 40 participants

Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use

Yale University

NCT06027840

RECRUITING NA 30 participants

Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures

Masonic Cancer Center, University of Minnesota

NCT06295757

ACTIVE NOT RECRUITING NA 940 participants

Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks

University of Colorado, Denver

NCT05641974

ACTIVE NOT RECRUITING NA 150 participants

Are Smokers Switching to Vaping at Lower Risk for Cancer? (Electronic Cigarettes and Cancer Risk)

University of Southern California

NCT03750825

COMPLETED NA 789 participants

The Effectiveness of Smoking Cessation Guidelines in the Emergency Department

University of Iowa

NCT00756704

COMPLETED NA 397 participants

Smoking Interventions for Hospital Patients

Massachusetts General Hospital

NCT01177176

COMPLETED NA 246 participants

Use and Harm Exposure in New Low Nicotine Cigarettes

University of Pennsylvania

NCT01202942

COMPLETED Phase 4 203 participants

Smoking Study With Behavioral Therapy for Hypertensive Patients

UConn Health

NCT00879177

COMPLETED NA 190 participants

Reducing Tobacco Use Disparities Among Low-Income Adults

Northwestern University

NCT03077737

COMPLETED NA 180 participants

Resistance Training as an Aid to Smoking Cessation Treatment

Teachers College, Columbia University

NCT01951456

COMPLETED NA 171 participants

Cigarette Smoking Among Young Adults

University of Oklahoma

NCT04340947

COMPLETED Phase 2 165 participants

Incentives for Oklahoma Tobacco Helpline Engagement in Persistent Poverty Counties

University of Oklahoma

NCT05095779

COMPLETED Phase 2 150 participants

Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment

Brown University

NCT00938886

COMPLETED Phase 2 142 participants

Treatment of Smoking Among Individuals With PTSD

University of Pennsylvania

NCT00937235

COMPLETED Early Phase 1 87 participants

Testing the ETM: Examination and Comparison of Different Methods

Virginia Polytechnic Institute and State University

NCT05946031

COMPLETED Phase 1 77 participants

Text Messaging-Based Smoking Cessation Program for Homeless Youth

RAND

NCT03874585

COMPLETED Phase 2 77 participants

E-cigarette Nicotine Study

University of Vermont

NCT04709471

COMPLETED NA 59 participants

Contingency Management and Pharmacotherapy for Smoking Cessation

UConn Health

NCT00683280

COMPLETED 50 participants

Brain Nicotine Receptor Density & Response to Nicotine Patch

Brentwood Biomedical Research Institute

NCT01526005

COMPLETED Phase 2 48 participants

Semaglutide for Alcohol Use Disorder

University of North Carolina, Chapel Hill

NCT05520775

COMPLETED Phase 2 38 participants

Treating Smokers With Mental Illness

University of Minnesota

NCT03822416

COMPLETED NA 36 participants

A Study to Assess the Pharmacokinetics of Oral Nicotine Pouches and Lozenges in Healthy Adults

British American Tobacco (Investments) Limited

NCT04755348

COMPLETED Phase 1 33 participants

Contingency Management, Quitting Smoking, and ADHD

Duke University

NCT02266784

COMPLETED NA 29 participants

Families With Substance Use and Psychosis: A Pilot Study

Mclean Hospital

NCT04284813

COMPLETED Phase 1 26 participants

New Approaches to Smoking Cessation in Heavy Drinkers

Yale University

NCT02151591

COMPLETED NA 17 participants

E-cigarettes for Harm Reduction in Adults With Asthma

Brown University

NCT05278065

COMPLETED Phase 1 12 participants

A Study of Inhalation of 20,000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers

University of North Carolina, Chapel Hill

NCT00924768

COMPLETED NA 9 participants

Behavioral Economic Methods for Assessing Tobacco Product Abuse Liability: Study 7

Virginia Polytechnic Institute and State University

NCT03496922

Phase Distribution

PhaseTrial count
Phase 1 7
Phase 2 8
Phase 4 2

Named interventions

Most-linked intervention names on Cigarette Smoking records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Varenicline Drug
4 trials
E-cigarettes Other
2 trials
Placebo Drug
2 trials
Hypothetical ETM Drug
1 trials
Reat ETM Drug
1 trials
Extended Care Management Other
1 trials
Quest Other
1 trials
behavioral therapy Behavioral
1 trials

US sites by state

Facility locations filed on Cigarette Smoking trials. A trial with sites in several states counts in each.

Pennsylvania 5 trials
Virginia 4 trials
South Carolina 4 trials
New York 4 trials
Connecticut 4 trials
Oklahoma 3 trials
North Carolina 3 trials
Illinois 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cigarette Smoking page

46 registered trials, 20 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cigarette Smoking condition card totals 46 registered trials; most-linked intervention Varenicline; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.